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Circulatory support with attenuated pulse pressure alters human aortic
wall morphology
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In biology “form follows function.” Hypertension causes themusculoelastic aortic wall to thicken.1 The only situationcharacterized by chronic hypotension with diminished pulsepressure is in patients having long-term support with a left
ventricular assist device (LVAD). In a sheep model of chronic
nonpulsatile blood flow, the medial layer thinned with apoptosis of
smooth muscle cells (SMCs) and fragmentation of elastic fibers.2
We sought to determine the clinical implications of this finding for
destination therapy patients with a rotary blood pump.
Clinical Summary
In 7 patients with end-stage heart failure, computed tomographic
scans were taken before implantation of a Jarvik 2000 LVAD
(Jarvik Heart, Inc, New York, NY) and then annually during
survival. Preoperative and latest postoperative aortic diameters
were compared. After 5 deaths at between 7 days and 34 months
of support, we obtained multiple full-thickness sections of the
descending thoracic aorta. At least two nonadjacent sections were
processed for each patient. The samples were fixed and stained
with hematoxylin and eosin (H&E) and elastic van Gieson (EVG)
stains. Control samples were taken from nonvasculopathic cadav-
ers of similar age, sex, and body mass. These were obtained by our
homograft valve bank with consent in accordance with the Human
Tissue Act (United Kingdom).
Thickness of the aortic medial layer was measured from an
average of 35 nonadjacent fields (EVG, magnification 40).
SMCs were counted from an average of 20 non-adjacent fields
(H&E, magnification 200) per patient. Data were analyzed with
StatsDirects (version 2.5.7; StatsDirect Ltd, Sale, Cheshire, United
Kingdom) and presented as median  SD. Analysis of variance
was calculated using 2-way analysis of variance with Bonferroni
comparison.
None of the computed tomographic scans showed an increase
in aortic diameter out to 6 years (Figure 1). The 7-day LVAD
specimens were indistinguishable from controls, but distinct mor-
phologic changes were evident in the 3-month samples. Medial
thickness diminished during prolonged support (1.411  0.140
mm in controls vs 1.006  0.170 mm in LVAD patients; P 
.0001). Medial SMCs decreased in number (147  31 per field in
controls vs 63  12 per field in LVAD patients; P  .0001)
(Figure 2). From the EVG-stained sections there was a concomi-
tant decrease in the medial layer elastin content. The process of
atrophy appeared to progress with time.
Discussion
These novel findings were predictable but have not previously
been confirmed in humans.
One study limitation is that the autopsy samples could not be
compared with the same patients’ aorta obtained during LVAD
implantation. However, we were initially unaware of the sheep
findings from our Terumo ventricular assist device program.2 It
was this that triggered the human study. Matched controls were the
alternative. Irrespective of this, the human changes closely parallel
the laboratory findings.3
Arteries remodel in response to pressure and flow to provide a
constant level of shear stress. Remodeling follows a complex
interaction between signaling pathways and altered gene expres-
sion for nitric oxide synthase, platelet-derived growth factor, and
transforming growth factor 1.4 Because the Jarvik 2000 LVAD is
afterload sensitive, mean systemic arterial blood pressure (MAP)
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Figure 1. Computed tomographic scan from a surviving patient 6
years after implantation of a Jarvik 2000 LVAD. There are no
changes in size at any level compared with the preoperative
scan. Preoperative scans are performed routinely to rule out
disease at the site of vascular graft anastomosis.
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was pharmacologically reduced to 70 to 90 mm Hg. Attenuated
pulse pressure between 10 and 20 mm Hg is usually detectable
through left ventricular contraction. In these circumstances, shear
stress is reduced through both nonpulsatile pump flow and MAP
reduction.
In hypertension, aortic hypertrophy results from stimulation
of angiotensin I receptor, which promotes SMC growth and
inhibits apoptosis. Angiotensin I receptor blockade (eg, losar-
tan) induces a transient burst of SMC apoptosis and regression
of medial hypertrophy.5 Angiotensin II receptors mediate vas-
cular mass regression by SMC apoptosis in vivo. In animal
models we and others have shown that SMC apoptosis occurs in
response to reduced arterial wall tension, suggesting that blood
pressure– dependent and angiotensin-independent apoptotic
pathways are possible.3 As well as medial thinning and dimin-
ished SMC number in goats, Nishimura and associates3 showed
an elevation in the number of inactive (atrophic) SMCs with
increased density. Atrophy of SMCs has also been demon-
strated in other models of hypotension, decreased aortic flow,
and hypoxia. Perhaps because of MAP control, the LVAD
patient’s aorta does not dilate during these morphologic
changes.
Evidence shows rotary blood pumps to be user friendly, safe,
and effective for prolonged periods. The aortic wall changes are
not likely to achieve clinical significance. On the contrary, the
potential therapeutic benefits of pulse pressure modulation in vas-
culopathic patients are compelling. Virtual elimination of pulse
pressure may prevent progression or even reverse arterial disease
or may prevent aneurysm rupture in poor surgical candidates. This
approach may prove feasible with the development of even smaller
devices that can be implanted without major surgery.
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Figure 2. SMC count from the aortic medial layer at different durations of support compared with control samples.
There is a statistically significant decrease in medial SMCs, which appears to progress with time.
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